Background
Methods
Patient population and establishment of PDX lines
Patient details | Xenograft details | ||||||||
---|---|---|---|---|---|---|---|---|---|
Pt ID | Receptor status | Subtype | Source of tissue | Sites of metastasis | Survival (months) | WHIM line | Mouse ID | Receptor status | Site of metastases |
262 | ER+/HER2- | Luminal-B | Breast | BN, CNS | 37 | 11 | 11E 1221 | ER+/HER2- | None |
303 | ER-/HER2- | Claudin-low | Breast | PL, PC | 12 | 12 | 12A 1282 | ER-/HER2- | L |
12A1291 | L | ||||||||
12C1363 | ER-/HER2- | H | |||||||
12C1264 | None | ||||||||
12C 1375 | None | ||||||||
12C 1376 | None | ||||||||
270 | ER-/HER2- | Basal | Chest wall | BR, CT, L, H, BN | 44+ b
| 13 | 13A 1204 | ER-/PR- | None |
7192 | ER-/HER2- | Claudin-low | Breast | None | 37+ b
| 17 | 17A 1384 | ER-/HER2- | H, N |
17B 1139 | ER-/HER2- | H | |||||||
17B 1141 | L | ||||||||
17B1188 | L, H | ||||||||
17B29 | L, H, S | ||||||||
17C1180 | ER-/HER2- | L | |||||||
17C1182 | L, H, S, K | ||||||||
319 | ER+/HER2- | Luminal-B | Skin | CT, N | 97 | 23 | 23C 1832 | None | |
23C 1833 | ER+/HER2- | None | |||||||
23C 1834 | None |
BM and RNA isolation
qRT-PCR
Microarray analysis
Results
Development of metastatic tumors correlates with presence of human cells in mouse BM
Human DTCs in mouse BM express markers of epithelial-mesenchymal transition (EMT)
Comparative molecular profiles of DTCs and their corresponding primary and metastatic tumors
Gene symbol | Gene name | Fold expression |
p value | Targetable |
---|---|---|---|---|
ALB
| Albumin | 97.6 | 2.77E-08 | |
IGF2
| Insulin-like growth factor 2 | 46.0 | 1.12E-06 | |
FABP1
| Fatty acid binding protein 1 | 37.0 | 3.21E-07 | |
GPC3
| Glypican 3 | 24.9 | 5.78E-09 | |
DCT
| Dopachrome tautomerase | 21.3 | 2.15E-07 | |
SPP1
| Secreted phosphoprotein 1 | 16.7 | 1.18E-07 | |
FGG
| Fibrinogen gamma chain | 16.5 | 2.56E-07 | |
FGA
| Fibrinogen alpha chain | 15.8 | 1.67E-07 | |
MAL2
| Mal, T-cell differentiation protein 2 | 14.2 | 3.75E-08 | |
APOB
| Apolipoprotein B | 12.2 | 2.62E-07 | |
CPE
| Carboxypeptidase E | 10.7 | 1.11E-06 | |
BAMBI
| BMP and activin membrane bound inhibitor | 9.6 | 0.00021247 | |
TYR
| Tyrosinase | 9.4 | 3.52E-07 | |
BCHE
| Butyrylcholinesterase | 8.8 | 1.02E-06 | |
CD24
| CD24 molecule | 8.7 | 1.55E-05 | |
LEF1
| Lymphoid enhancer binding factor 1 | 8.2 | 0.0001236 | |
TSPAN8
| Tetraspanin 8 | 6.8 | 9.95E-06 | |
SERPINA1
| Serpin family A member 1 | 6.2 | 2.00E-05 | |
CGA
| Glycoprotein hormones, alpha polypeptide | 6.2 | 7.70E-05 | |
AZGP1
| Alpha-2-glycoprotein 1, zinc-binding | 6.2 | 0.00126944 | |
TFF1
| Trefoil factor 1 | 6.2 | 3.83E-05 | |
HGD
| Homogentisate 1,2-dioxygenase | 5.9 | 6.49E-05 | |
TYRP1
| Tyrosinase related protein 1 | 5.2 | 2.68E-05 | |
DSP
| Desmoplakin | 5.1 | 8.91E-05 | |
C3
| Complement C3 | 5.1 | 0.00067128 | |
SLPI
| Secretory leukocyte peptidase inhibitor | 5.1 | 7.24E-05 |
Gene symbol | Gene name | Fold expression |
p value | Targetable |
---|---|---|---|---|
CD53
| CD53 molecule | 4.1 | 0.0006062 | |
PTPRC
| Protein tyrosine phosphatase, receptor type C | 3.7 | 0.00474656 | |
KIR3DL1
| Killer cell immunoglobulin like receptor, three Ig domains and long Cytoplasmic Tail 1 | 3.2 | 0.00145097 | |
HBA1
| Hemoglobin subunit alpha 1 | 2.7 | 0.00117262 | |
MT3
| Metallothionein 3 | 2.7 | 0.00033581 | |
HBB
| Hemoglobin subunit beta | 2.7 | 0.00086439 | |
OSM
| Oncostatin M | 2.5 | 0.00677886 | |
MAP2K6
| Mitogen-activated protein kinase kinase 6 | 2.5 | 0.00632423 | |
ARHGDIB
| Rho GDP dissociation inhibitor beta | 2.4 | 0.00115363 | |
SLPI
| Secretory leukocyte peptidase inhibitor | 2.3 | 0.00071176 | |
DDC
| Dopa Decarboxylase | 2.3 | 0.00080507 | Yes [40] |
SSTR4
| Somatostatin receptor 4 | 2.3 | 0.00058499 | |
MAPT
| Microtubule associated protein tau | 2.3 | 0.0010915 | |
HPR
| Haptoglobin-related protein | 2.3 | 0.00139515 | |
SPN
| Sialophorin | 2.3 | 0.00092894 | |
HLA-B
| Major histocompatibility complex, class I, B | 2.2 | 4.27E-05 | |
CISH
| Cytokine inducible SH2 containing protein | 2.2 | 0.00021425 | |
MST4
| Serine/threonine protein kinase 26 | 2.1 | 0.0035196 | |
SERPINA5
| Serpin family A member 5 | 2.1 | 0.00622652 | |
PTPN6
| Protein tyrosine phosphatase, non-receptor type 6 | 2.1 | 0.00735724 | |
MMP17
| Matrix metallopeptidase 17 | 2.1 | 0.00493339 | |
CEACAM6
| Carcinoembryonic antigen related cell adhesion molecule 6 | 2.0 | 0.00179388 |
The molecular profiles of PDX DTCs are also found in BM from patients with breast cancer
Gene | Gene name | Drugs available against target gene |
---|---|---|
CD163
| CD163 molecule | |
PDGFC
| Platelet derived growth factor C | |
GLIPR1
| GLI pathogenesis related 1 | |
ANXA5
| Annexin A5 | |
CPVL
| Carboxypeptidase, vitellogenic like | |
PF4
| Platelet factor 4 | |
CYP1B1
| Cytochrome P450 family 1 subfamily B member 1 | Yes [43] |
EPB41L3
| Erythrocyte membrane protein band 4.1 like 3 | |
MEIS1
| Meis homeobox 1 | |
TNFRSF17
| TNF receptor superfamily member 17 | |
DLC1
| DLC1 rho GTPase activating protein | |
HEBP1
| Heme binding protein 1 | |
CFDP1
| Craniofacial development protein 1 | |
CD36
| CD36 molecule | |
CD33
| CD33 molecule | |
UGDH
| UDP-glucose 6-dehydrogenase | |
CD44
| CD44 molecule |